Results 191 to 200 of about 190,897 (242)

Impact of frailty on outcomes of inpatient stereotactic radiosurgery for brain metastasis: a national readmission database analysis 2016-2020. [PDF]

Radiat Oncol
Chan RWY, Wang CK, Lo WL, Yeh TH, Savaraj N, Feun LG, Chen SM.   +6 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

The epigenetic landscape of brain metastasis. [PDF]

Oncogene
Powell AM, Watson L, Luzietti L, Prekovic S, Young LS, Varešlija D.   +5 more
europepmc   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Discovery of potent and brain-penetrable tubulin inhibitors that effectively suppress breast cancer brain metastasis. [PDF]

Mol Cancer Ther
Krutilina RI, Adeleye KL, Playa HC, Pochampally S, Banjeree S, Oluwalana D, Kamal MS, Tian D, Miller DD, Li W, Seagroves TN.   +10 more
europepmc   +1 more source

Cystic brain metastasis

, 2020
openaire   +1 more source

Main factors associated with variability in the assessment of the objective response rate. A re‐analysis of the PHEREXA phase 3 clinical trial

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Local investigators (LIs) overestimate the objective response rate (ORR) in comparison to Blinded Independent Central Reviewers (BICR) in oncology. In this study, we re‐analysed data obtained in the PHEREXA trial (NCT01026142) with the following aims: i) to confirm at the single‐patient level the discrepancy observed by analysing ...
Gennaro Daniele, Tommaso Giovagnoli, Pierluigi Navarra, Cinzia Dello Russo   +3 more
wiley   +1 more source

Assessing brain metastasis response to immunotherapy: a pictorial review of atypical responses and intracranial adverse events. [PDF]

Insights Imaging
Amseian G, Aya F, Pineda C, González-Ortiz S, Mora JA, Olondo ML, Perissinotti A, Caballero GA, Aldecoa I, Mezquita L, Puig J, Arance A, Bargalló N, Oleaga L.   +13 more
europepmc   +1 more source

Optimizing ribociclib dosing in breast cancer with brain metastasis patients using a physiologically based pharmacokinetic model. [PDF]

BMC Cancer
Zhang C, Li S, Ren J, Wen X.
europepmc   +1 more source

Identification of altered immune landscape at single-cell resolution in NSCLC brain metastasis and its association with poor immune checkpoint inhibitor responses. [PDF]

Nat Commun
Bai M, Yin T, Li X, Wang P, Lei T, Jin P, Li F, Guo H, Guo X, Sun X, Li Y, Zou B, Yu J, Liu C, Teng F.   +14 more
europepmc   +1 more source